Cetuximab Boosts Survival in Patients With Liver MetsCetuximab Boosts Survival in Patients With Liver Mets

Cetuximab combined with chemotherapy improved the resectability of liver metastases and survival in patients with KRAS wild-type colorectal cancer. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news